Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use, reply to letter

International Journal of Clinical Pharmacy

Volumn 33, Issue 5, 2011, Pages 722-723

  Duran Garcia, Esther ^a   Santos Ramos, Bernardo ^a   Puigventós Latorre, Francesc ^a   Ortega, Ana ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HOSPITAL PHARMACY; LETTER; OFF LABEL DRUG USE; PHARMACY AND THERAPEUTICS COMMITTEE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPAIN;

EID: 83255187283     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9537-7     Document Type: Letter

References (5)

1. Durán-García E, Santos-Ramos B, Puigventos-Latorre F, Ortega A. Literature review on the structure and operation of pharmacy and therapeutics committees. Int J Clin Pharm. 2011;33:475-83.
2. Delgado O, Puigventós F, Clopés A. Position of the hospital pharmacist regarding the use of medication in non-authorised conditions. Farm Hosp. 2009;33:237-239, Spanish.
3. Puigventós F, Santos-Ramos B, Ortega A, Durán-García E. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals. Pharm World Sci. 2010;32:767-75.
4. Group for Innovation, Assessment, Standardisation and Research in the Selection of Drugs of the Spanish Society of Hospital Pharmacy. Drug use in conditions other than those authorized in data sheet. http://gruposdetrabajo. sefh.es/genesis/genesis/Enlaces/ PNT-FFT-GENESIS-Borrador-07-11-2009.pdf. Accessed 31 May 2011.
5. de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to good prescribing. A practical manual. World Health Organization ed. Geneve; 1994.